Filing Details
- Accession Number:
- 0001363213-12-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-04-04 12:53:27
- Reporting Period:
- 2011-11-30
- Filing Date:
- 2012-04-04
- Accepted Time:
- 2012-04-04 12:53:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 880771 | Sciclone Pharmaceuticals Inc | SCLN | Pharmaceutical Preparations (2834) | 943116852 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1363213 | Friedhelm Blobel | 950 Tower Lane, Suite 900 Foster City CA 94404 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-11-30 | 1,000 | $3.78 | 38,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2012-02-29 | 1,000 | $3.78 | 39,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Acquisiton | 2012-03-15 | 200,000 | $0.00 | 200,000 | $6.22 |
| Common Stock | Restricted Stock Unit | Acquisiton | 2012-03-20 | 75,000 | $0.00 | 75,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 200,000 | 2022-03-15 | No | 4 | A | Direct | |
| 103,070 | No | 4 | A | Direct |
Footnotes
- Purchased under the Issuer's Employee Stock Purchase Plan on November 30, 2011.
- Purchased under the Issuer's Employee Stock Purchase Plan on February 29, 2012.
- Granted under the Issuer's 2005 Equity Incentive Plan.
- 25% of such shares vest one year from the date of grant and 2.0833% vests each month thereafter, provided that Reporting Person continues to be employed by the Issuer.
- Each restricted stock unit represents the contingent right to receive one share of SciClone Pharmaceuticals, Inc.'s common stock.
- 100% of the restricted stock units will vest on February 25, 2014, unless the trading window is closed for the Reporting Person on that date, then the vesting date will be deferred until the next date that the trading window is open.
- 100% of the restricted stock units will vest on February 25, 2014, unless the trading window is closed for the Reporting Person on that date, then the vesting date will be deferred until the next date that the trading window is open.
Billionaire Hedge Funds
